
浏览全部资源
扫码关注微信
1.广州中医药大学 青蒿研究中心,广州 510405
2.广州中医药大学科技产业园有限公司,广州 510445
3.成都中医药大学,成都 610072
郑绍琴,在读博士,中级药师,从事中药药理与药效研究,E-mail:49199500@qq.com
宋健平,博士生导师,研究员,从事经方治疗重大疾病研究,Tel:020-87473318,E-mail:songjpgz@sina.com
收稿日期:2021-06-07,
网络出版日期:2022-01-04,
纸质出版日期:2022-03-05
移动端阅览
郑绍琴,秦凯华,张首亚等.经典名方真武汤对大鼠血液指标和组织病理的影响[J].中国实验方剂学杂志,2022,28(05):86-94.
ZHENG Shao-qin,QIN Kai-hua,ZHANG Shou-ya,et al.Effect of Zhenwutang on Blood Indexes and Histopathology in Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(05):86-94.
目的
2
观察经典名方真武汤长期应用对大鼠血液指标和组织病理的安全性影响。
方法
2
采用SD大鼠进行灌胃给药30 d毒性实验。按体质量和性别随机分为4组,每组32只,雌雄各半,分别为真武汤低、中、高剂量(生药16,24,36 g·kg
-1
)3个剂量组(等效于真武汤临床剂量的20,30,45倍)及1个空白组(纯净水);每天上午灌胃给药1次,连续给药30 d,停药后观察14 d;每周测量体质量和摄食量1次,并根据所称体质量更换给药量;实验期间每天进行1次一般观察;分别于给药前1 d(D
-1
),给药后4 h(D
0
),给药第15天(D
14
),给药结束(D
29
)和恢复期结束(D
43
)测量大鼠心电图1次;于给药结束(D
30
)和恢复期结束(D
44
)对部分大鼠(每次64只)进行血液和各组织病理学检查。
结果
2
与空白组比较,真武汤高剂量组(D
8
~D
35
),中剂量组(D
13
~D
35
),低剂量组(D
15
~D
33
)部分大鼠出现脱毛现象,主要脱毛部位出现在项颈部。与空白组比较,真武汤中、高剂量组雌性大鼠给药D
7
体质量明显降低(
P
<
0.05);真武汤低剂量组在给药D
21
和D
29
大鼠体质量明显降低(
P
<
0.05);真武汤中、高剂量组在给药D
7
~D
29
大鼠体质量有不同程度的降低(
P
<
0.05)。与空白组比较,给药第1周,真武汤低、中、高剂量组大鼠摄食量明显减少(
P
<
0.05);雄性大给药第1,2周,真武汤中、高剂量组大鼠摄食量和给药第4周高剂量组大鼠摄食量明显减少(
P
<
0.05)。与空白组比较,雌性大鼠在给药D
14
,真武汤中、高剂量组大鼠心率明显加快(
P
<
0.05);雄性大鼠在给药D
14
和D
29
,真武汤低、中、高剂量组大鼠心率明显加快(
P
<
0.05);雄性大鼠在给药D
14
和D
29
,真武汤中剂量组大鼠P波时间延长(
P
<
0.05);雌性大鼠在给药D
14
天,真武汤中、高剂量组大鼠QRS间期延长(
P
<
0.05);雌性大鼠在给药D
14
天,真武汤高剂量组大鼠S波波幅明显降低(
P
<
0.05);雄性大鼠在给药D
14
和D
29
,真武汤中、高剂量组大鼠S波波幅明显降低(
P
<
0.05)。实验显示低、中、高剂量真武汤对SD大鼠灌胃给药30 d毒性实验,可导致大鼠脱毛,体质量下降,饮食不佳,心率加快,心率不齐,对血液学检测(血常规、凝血四项和血生化)指标影响不明显,病理检查亦无明显变化。
结论
2
真武汤有正性肌力作用,临床45倍量无明显毒性作用,但要注意预防室性早搏的发生。
Objective
2
To observe the long-term safety of Zhenwutang on blood indexes and histopathology in SD rats.
Method
2
The acute toxicity test was conducted to evaluate the acute toxicity of Zhenwutang toward SD rats. The SD rats were randomly assigned into 4 groups (low-, medium-, and high-dose Zhenwutang and control group), with 32 rats (16 males and 16 females) in each group. The rats were administrated once daily with Zhenwutang respectively at the doses of 16, 24, and 36 g·kg
-1
(equal to 20, 30, 45 times of clinical dose) for 30 days, and those in the control group with purified water. After administration, the rats were observed for another 14 days. The body weight and food intake were measured once a week and the dosage was changed according to the body weight. General observation was carried out once a day during the experiment period. The electrocardiogram (ECG) was measured a day before administration (D
-1
), 4 h after administration (D
0
), on day 15 of administration (D
14
), and at the end of administration (D
29
) and the end of recovery period (D
43
). At the end of administration (D
30
) and the end of recovery period (D
44
), the blood assay and histopathological examinations were performed for 64 rats.
Result
2
Compared with control group,some rats in zhenwutang high-dose group (D
8
-D
35
), medium-dose group (D
13
-D
35
) and low-dose group (D
15
-D
33
) showed depilation, mainly in the neck.Compared with the control group, rat body weight of D
7
in Zhenwutang medium-dose and high-dose groups had significantly decreased,rat body weight of D
21
and D
29
in Zhenwutang low-dose group had decreased too.During D
7
-D
29
, body weight of rats in Zhenwutangn medium-dose and high-dose groups had differently decreased.Compared with control group, food intake in Zhenwutang low-dose, medium-dose and high-dose groups had significantly reduced in the first week. The food intake of male rats in Zhenwutang medium-dose and high-dose groups had significantly decreased in the first, second and fourth week .Compared with control group, the heart rate of female rats in Zhenwutang medium-dose and high-dose groups had increased. In the D
14
and D
29
days, the heart rate of male rats in Zhenwutang low-dose, medium-dose and high-dose groups had increased. The P wave time of male rats in Zhenwutang medium-dose group have prolonged. The QRS interval of female rats in Zhenwutang medium-dose and high-dose groups had prolonged. After 14 days of administration, the s-wave amplitude of Zhenwutang high-dose group had significantly decreased. After D
14
and D
29
days of administration, the s-wave amplitude of Zhenwutang in middle and high dose groups had significantly decreased.This study showed that intragastric administration of Zhenwutang for 30 days caused hair loss, weight loss, poor appetite, increased heart rate, and irregular heart rate of SD rats. It had little effect on the hematological indicators and did not cause obvious changes in pathological and blood indicators.
Conclusion
2
Zhenwutang exerts positive inotropic effect, and 45 times of the clinical dose has no obvious toxic effect. However, attention should be paid to preventing the occurrence of ventricular premature beat.
孟涌生 . 真武汤的现代研究 [J]. 北京中医 , 2007 , 26 ( 9 ): 628 - 631 .
梁华龙 , 李姗姗 , 郭芳 . 真武汤利水作用机制的实验研究 [J]. 北京中医药大学学报 , 1999 , 22 ( 2 ): 68 - 70 .
布天杰 , 潘雨烟 , 张宁 . 真武汤治疗糖尿病肾病作用机制的网络药理学研究 [J]. 世界中医药 , 2020 , 15 ( 24 ): 3719 - 3727 .
王东升 , 赵鸣芳 . 也谈真武汤中芍药的意义 [J]. 中华中医药杂志 , 2018 , 33 ( 1 ): 53 - 55 .
陈澄 , 黄平 . 黄平运用真武汤合方经验举隅 [J]. 浙江中西医结合杂志 , 2018 , 28 ( 12 ): 1064 - 1065 .
龙新生 , 吕萍 , 莫劲松 , 等 . 加味真武汤对充血性心力衰竭少阴病阳虚水停证兔内皮素的影响 [J]. 中国中西医结合急救杂志 , 2003 , 10 ( 5 ): 287 - 289 .
杜丽 , 熊曼琪 , 梅国强 , 等 . 加味真武汤对充血性心力衰竭少阴病阳虚水停证兔心肌细胞凋亡的影响 [J]. 中国医药学报 , 2000 , 15 ( 2 ): 26 - 29,38 .
吕萍 , 莫劲松 , 王菊萍 , 等 . 加味真武汤对充血性心力衰竭少阴病阳虚水停证兔血流动力学的影响 [J]. 中国中医药信息杂志 , 2004 , 11 ( 6 ): 489 - 491 .
朱章志 , 龙新生 . 加味真武汤对充血性心衰模型血流动力学及血管紧张素Ⅱ的影响 [J]. 中药新药与临床药理 , 2001 , 12 ( 5 ): 342 - 344 .
陈建杉 , 杨殿兴 , 江泳 . 真武汤对肺心病并右心衰激素水平影响的实验研究 [J]. 成都中医药大学学报 , 2004 , 27 ( 3 ): 46 - 48 .
朱奔奔 , 郭维 , 黄亮 , 等 . 真武汤对慢性充血性心力衰竭模型大鼠ET、CGRP水平的影响 [J]. 江苏中医药 , 2005 , 37 ( 8 ): 49 - 51 .
王均宁 , 龙子江 , 王钦茂 . 真武汤及其拆方强心利尿作用的实验研究 [J]. 中成药 , 1997 , 19 ( 3 ): 27 - 29 .
李小茜 , 何建成 . 真武汤治疗心力衰竭的理论与应用之思考 [J]. 中华中医药学刊 , 2021 , 39 ( 12 ): 74 - 78,278 .
周文付 , 程晓昱 , 杜卫甫 , 等 . 真武汤治疗慢性心力衰竭作用机制研究进展 [J]. 辽宁中医药大学学报 , 2017 , 19 ( 11 ): 218 - 221 .
伍燕宏 , 郑景辉 , 朱梓铭 , 等 . 真武汤治疗慢性心力衰竭的网络药理学机制研究 [J]. 广州中医药大学学报 , 2019 , 39 ( 10 ): 1617 - 1623 .
耿建国 , 刘根尚 , 齐昉 . 真武汤合桃核承气汤对人胎肾小球系膜细胞外基质不同影响的实验研究 [J]. 山东中医杂志 , 2003 , 22 ( 12 ): 747 - 748 .
何岚 , 蔡宇 , 陈朝晖 , 等 . 真武汤对大鼠阿霉素肾病的治疗作用及其机理研究 [J]. 中国实验方剂学杂志 , 2006 , 12 ( 2 ): 51 - 53 .
王钰霞 , 陈魁敏 , 郝伟 , 等 . 真武汤的药效学研究 [J]. 辽宁中医杂志 , 2000 , 27 ( 12 ): 565 - 566 .
申安 , 袁洋 , 岳园园 , 等 . 真武胶囊安全性评价研究 [J]. 中医研究 , 2015 , 28 ( 8 ): 61 - 64 .
梁春玲 , 周玖瑶 , 周园 , 等 . 真武汤对渗透泵恒释ADR肾病综合征大鼠的干预作用 [J]. 中国实验方剂学杂志 , 2013 , 19 ( 6 ): 215 - 219 .
国务院 . 中华人民共和国中医药法 [EB/OL].( 2017-09-08 )[ 2021-06-07 ]. http://www.gov.cn/xinwen/2016-12/26/ content _5152773.htm http://www.gov.cn/xinwen/2016-12/26/content_5152773.htm .
国家食品药品监督管理总局.中药、天然药长期毒性研究技术指导原则 [Z]GP T3-1,2005 .
朱林平 . 附子毒性研究概况 [J]. 江西中医药 , 2004 , 35 ( 6 ): 53 - 55 .
0
浏览量
22
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621